Brian Millham - Dec 22, 2024 Form 4 Insider Report for Salesforce, Inc. (CRM)

Role
President and COO
Signature
/s/ Sarah Dale, Attorney-in-Fact for Brian Millham
Stock symbol
CRM
Transactions as of
Dec 22, 2024
Transactions value $
-$2,259,491
Form type
4
Date filed
12/23/2024, 08:22 PM
Previous filing
Nov 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRM Common Stock Options Exercise $0 +1.63K $0.00 1.63K Dec 22, 2024 Direct
transaction CRM Common Stock Options Exercise $0 +1.71K +104.41% $0.00 3.34K Dec 22, 2024 Direct
transaction CRM Common Stock Sale -$279K -821 -24.58% $339.78 2.52K Dec 23, 2024 Direct F1
transaction CRM Common Stock Sale -$291K -857 -34.02% $339.78 1.66K Dec 23, 2024 Direct F1
transaction CRM Common Stock Options Exercise $380K +2.04K +122.62% $186.51 3.7K Dec 23, 2024 Direct F2
transaction CRM Common Stock Options Exercise $434K +2.02K +54.54% $215.17 5.72K Dec 23, 2024 Direct F2
transaction CRM Common Stock Options Exercise $460K +2.11K +36.85% $218.21 7.83K Dec 23, 2024 Direct F2
transaction CRM Common Stock Options Exercise $2.08M +8.65K +110.49% $240.95 16.5K Dec 23, 2024 Direct F2
transaction CRM Common Stock Sale -$1.27M -3.75K -22.77% $339.36 12.7K Dec 23, 2024 Direct F2, F3
transaction CRM Common Stock Sale -$1.54M -4.54K -35.66% $340.02 8.18K Dec 23, 2024 Direct F2, F4
transaction CRM Common Stock Sale -$205K -600 -7.33% $341.04 7.58K Dec 23, 2024 Direct F2, F5
transaction CRM Common Stock Sale -$2.03M -5.92K -78.09% $342.25 1.66K Dec 23, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRM Restricted Stock Units Options Exercise $0 -1.63K -49.98% $0.00 1.64K Dec 22, 2024 Common Stock 1.63K $0.00 Direct F6, F7
transaction CRM Restricted Stock Units Options Exercise $0 -1.71K -16.66% $0.00 8.53K Dec 22, 2024 Common Stock 1.71K $0.00 Direct F6, F8
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -2.04K -3.57% $0.00 55K Dec 23, 2024 Common Stock 2.04K $186.51 Direct F2, F9
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -2.02K -25% $0.00 6.05K Dec 23, 2024 Common Stock 2.02K $215.17 Direct F2, F10
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -2.11K -6.25% $0.00 31.6K Dec 23, 2024 Common Stock 2.11K $218.21 Direct F2, F11
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -8.65K -33.33% $0.00 17.3K Dec 23, 2024 Common Stock 8.65K $240.95 Direct F2, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents a sale of shares to satisfy the tax withholding obligations of the Issuer with respect to the settlement of shares that were earned by the holder pursuant to a restricted stock unit award that vested based on the holder's continued employment through December 22, 2024.
F2 As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2023.
F3 Weighted average price. These shares were sold in multiple transactions at prices ranging from $338.7600 to $339.7300 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F4 Weighted average price. These shares were sold in multiple transactions at prices ranging from $339.7600 to $340.4350 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F5 Weighted average price. These shares were sold in multiple transactions at prices ranging from $340.8500 to $341.6600 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F6 Restricted Stock Units convert to shares of common stock on a one-for-one basis.
F7 These restricted stock units vest as to 25% of the original grant on March 22, 2022, and vest as to 1/16 of the original grant quarterly thereafter.
F8 These restricted stock units vest as to 25% of the original grant on March 22, 2023, and vest as to 1/16 of the original grant quarterly thereafter.
F9 Option vests over four years at the rate of 25% on March 22, 2024, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
F10 Option vests over four years at the rate of 25% on March 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
F11 Option vests over four years at the rate of 25% on March 22, 2023, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
F12 Option vests over four years at the rate of 25% on February 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.